Mechanisms predisposing to childhood overgrowth and cancer

Current Opinion in Genetics and Development

Volumn 15, Issue 3 SPEC. ISS., 2005, Pages 227-233

  Rahman, Nazneen ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX CARCINOMA; BECKWITH WIEDEMANN SYNDROME; CANCER CLASSIFICATION; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD GROWTH; CHILDHOOD CANCER; EPIGENETICS; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GONADOBLASTOMA; GROWTH DISORDER; HEPATOBLASTOMA; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; MOLECULAR DYNAMICS; NEPHROBLASTOMA; NEUROBLASTOMA; NSD1 GENE; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; SOTOS SYNDROME;

EID: 19444369699     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2005.04.007     Document Type: Review

References (47)

1. D.M. Green, N.E. Breslow, J.B. Beckwith, and P. Norkool Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the national Wilms Tumor study Med Pediatr Oncol 21 1993 188 192
2. M. Elliott, and E.R. Maher Beckwith-Wiedemann syndrome J Med Genet 31 1994 560 564
3. R. Weksberg, A.C. Smith, J. Squire, and P. Sadowski Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development Hum Mol Genet 12 Spec No. 1 2003 R61 R68 An excellent review of the complex epigenetic mechanisms underlying Beckwith-Wiedemann syndrome.
4. N.J. Smilinich, C.D. Day, G.V. Fitzpatrick, G.M. Caldwell, A.C. Lossie, P.R. Cooper, A.C. Smallwood, J.A. Joyce, P.N. Schofield, and W. Reik A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome Proc Natl Acad Sci USA 96 1999 8064 8069
5. W.W. Lam, I. Hatada, S. Ohishi, T. Mukai, J.A. Joyce, T.R. Cole, D. Donnai, W. Reik, P.N. Schofield, and E.R. Maher Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation J Med Genet 36 1999 518 523
6. D. Catchpoole, W.W. Lam, D. Valler, I.K. Temple, J.A. Joyce, W. Reik, P.N. Schofield, and E.R. Maher Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome J Med Genet 34 1997 353 359
7. W. Reik, K.W. Brown, H. Schneid, Y. Le Bouc, W. Bickmore, and E.R. Maher Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain Hum Mol Genet 4 1995 2379 2385
8. •].
9. •] describe heritable microdeletions within IC1 and IC2, respectively, as novel causes of Beckwith-Wiedemann syndrome.
10. H.R. Wiedemann Tumors and hemihypertrophy associated with Wiedemann-Beckwith syndrome Eur J Pediatr 141 1983 129
11. J. Bliek, C. Gicquel, S. Maas, V. Gaston, Y. Le Bouc, and M. Mannens Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS) J Pediatr 145 2004 796 799 The authors report a sizeable number of French and Dutch BWS cases that were analysed for methylation defects at IC1 and IC2. They put these data together with the results of the following two studies [ 12,13 ] to show a strong correlation between epigenotype and Wilms tumor risk.
12. M.R. Debaun, E.L. Niemitz, D.E. McNeil, S.A. Brandenburg, M.P. Lee, and A.P. Feinberg Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects Am J Hum Genet 70 2002 604 611
13. R. Weksberg, J. Nishikawa, O. Caluseriu, Y.L. Fei, C. Shuman, C. Wei, L. Steele, J. Cameron, A. Smith, and I. Ambus Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1 Hum Mol Genet 10 2001 2989 3000
14. O. Ogawa, M.R. Eccles, J. Szeto, L.A. McNoe, K. Yun, M.A. Maw, P.J. Smith, and A.E. Reeve Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumor Nature 362 1993 749 751
15. T.R. Cole, and H.E. Hughes Sotos syndrome: a study of the diagnostic criteria and natural history J Med Genet 31 1994 20 32
16. K. Tatton-Brown, and N. Rahman Clinical features of NSD1-positive Sotos syndrome Clin Dysmorphol 13 2004 199 204 This study redefines the clinical features of Sotos syndrome on the basis of data from more than 100 individuals with confirmed abnormalities of NSD1.
17. K. Imaizumi, J. Kimura, M. Matsuo, K. Kurosawa, M. Masuno, N. Niikawa, and Y. Kuroki Sotos syndrome associated with a de novo balanced reciprocal translocation t(5;8)(q35;q24.1) Am J Med Genet 107 2002 58 60
18. N. Kurotaki, K. Imaizumi, N. Harada, M. Masuno, T. Kondoh, T. Nagai, H. Ohashi, K. Naritomi, M. Tsukahara, and Y. Makita Haploinsufficiency of NSD1 causes Sotos syndrome Nat Genet 30 2002 365 366
19. N. Kurotaki, N. Harada, O. Shimokawa, N. Miyake, H. Kawame, K. Uetake, Y. Makita, T. Kondoh, T. Ogata, and T. Hasegawa Fifty microdeletions among 112 cases of Sotos syndrome: low copy repeats possibly mediate the common deletion Hum Mutat 22 2003 378 387
20. J. Douglas, S. Hanks, I.K. Temple, S. Davies, A. Murray, M. Upadhyaya, S. Tomkins, H.E. Hughes, T.R. Cole, and N. Rahman NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes Am J Hum Genet 72 2003 132 143 This report and those by Rio et al. [21] and Turkmen et al. [22] demonstrate that NSD1 mutations are the major cause of Sotos syndrome outside Japan and that microdeletions occur in only 10% of cases.
21. M. Rio, L. Clech, J. Amiel, L. Faivre, S. Lyonnet, M. Le Merrer, S. Odent, D. Lacombe, P. Edery, and R. Brauner Spectrum of NSD1 mutations in Sotos and Weaver syndromes J Med Genet 40 2003 436 440
22. S. Turkmen, G. Gillessen-Kaesbach, P. Meinecke, B. Albrecht, L.M. Neumann, V. Hesse, S. Palanduz, S. Balg, F. Majewski, and S. Fuchs Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes Eur J Hum Genet 11 2003 858 865
23. N. Miyake, N. Kurotaki, H. Sugawara, O. Shimokawa, N. Harada, T. Kondoh, M. Tsukahara, S. Ishikiriyama, T. Sonoda, and Y. Miyoshi Preferential paternal origin of microdeletions caused by prezygotic chromosome or chromatid rearrangements in sotos syndrome Am J Hum Genet 72 2003 1331 1337 The authors demonstrate that Japanese microdeletion cases are typically paternally derived and usually arise through intrachromosomal events.
24. •].
25. •].
26. •] show that the deletion size and mechanism of generation is more variable in cases outside Japan.
27. N. Kurotaki, N. Harada, K. Yoshiura, S. Sugano, N. Niikawa, and N. Matsumoto Molecular characterization of NSD1, a human homologue of the mouse Nsd1 gene Gene 279 2001 197 204
28. N. Huang, E. vom Baur, J.M. Garnier, T. Lerouge, J.L. Vonesch, Y. Lutz, P. Chambon, and R. Losson Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators EMBO J 17 1998 3398 3412
29. G.V. Rayasam, O. Wendling, P.O. Angrand, M. Mark, K. Niederreither, L. Song, T. Lerouge, G.L. Hager, P. Chambon, and R. Losson NSD1 is essential for early post-implantation development and has a catalytically active SET domain EMBO J 22 2003 3153 3163 The authors describe the phenotype of Nsd1-null mice and demonstrate that NSD1 has an active SET domain that methylates H3-K36 and H4-K20.
30. B.D. Strahl, P.A. Grant, S.D. Briggs, Z.W. Sun, J.R. Bone, J.A. Caldwell, S. Mollah, R.G. Cook, J. Shabanowitz, D.F. Hunt, and C.D. Allis Set2 is a nucleosomal histone H3-selective methyltransferase that mediates transcriptional repression Mol Cell Biol 22 2002 1298 1306
31. K. Nishioka, J.C. Rice, K. Sarma, H. Erdjument-Bromage, J. Werner, Y. Wang, S. Chuikov, P. Valenzuela, P. Tempst, and R. Steward PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin Mol Cell 9 2002 1201 1213
32. A.L. Nielsen, P. Jorgensen, T. Lerouge, M. Cervino, P. Chambon, and R. Losson Nizp1, a novel multitype zinc finger protein that interacts with the NSD1 histone lysine methyltransferase through a unique C2HR motif Mol Cell Biol 24 2004 5184 5196
33. L. de Boer, H.A. Van Duyvenvoorde, E.C. Willemstein-Van Hove, C.M. Hoogerbrugge, J. Van Doorn, J.A. Maassen, M. Karperien, and J.M. Wit Mutations in the NSD1 gene in patients with Sotos syndrome associate with endocrine and paracrine alterations in the IGF system Eur J Endocrinol 151 2004 333 341
34. J.M. Wit, F.A. Beemer, P.G. Barth, J.W. Oorthuys, P.F. Dijkstra, J.L. Van den Brande, and N.J. Leschot Cerebral gigantism (Sotos syndrome). Compiled data of 22 cases. Analysis of clinical features, growth and plasma somatomedin Eur J Pediatr 144 1985 131 140
35. M.M. Cohen Jr. Tumors and nontumors in Sotos syndrome Am J Med Genet 84 1999 173 175
36. M.M. Cohen Jr. Overgrowth syndromes: an update Adv Pediatr 46 1999 441 491
37. J.H. Hersh, T.R. Cole, A.S. Bloom, S.J. Bertolone, and H.E. Hughes Risk of malignancy in Sotos syndrome J Pediatr 120 1992 572 574
38. T. Nagai, N. Matsumoto, N. Kurotaki, N. Harada, N. Niikawa, T. Ogata, K. Imaizumi, K. Kurosawa, T. Kondoh, and H. Ohashi Sotos syndrome and haploinsufficiency of NSD1: clinical features of intragenic mutations and submicroscopic deletions J Med Genet 40 2003 285 289
39. M.A. Deardorff, M. Maisenbacher, and E.H. Zackai Ganglioglioma in a Sotos syndrome patient with an NSD1 deletion Am J Med Genet 130A 2004 393 394
40. T.R. Cole, H.E. Hughes, M.J. Jeffreys, G.T. Williams, and M.M. Arnold Small cell lung carcinoma in a patient with Sotos syndrome: are genes at 3p21 involved in both conditions? J Med Genet 29 1992 338 341
41. R.J. Jaju, C. Fidler, O.A. Haas, A.J. Strickson, F. Watkins, K. Clark, N.C. Cross, J.F. Cheng, P.D. Aplan, and L. Kearney A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia Blood 98 2001 1264 1267
42. C. Panarello, C. Rosanda, and C. Morerio Cryptic translocation t(5;11)(q35;p15.5) with involvement of the NSD1 and NUP98 genes without 5q deletion in childhood acute myeloid leukemia Genes Chromosomes Cancer 35 2002 277 281
43. J. Brown, M. Jawad, S.R. Twigg, K. Saracoglu, A. Sauerbrey, A.E. Thomas, R. Eils, J. Harbott, and L. Kearney A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay Blood 99 2002 2526 2531
44. C. Slape, and P.D. Aplan The role of NUP98 gene fusions in hematologic malignancy Leuk Lymphoma 45 2004 1341 1350
45. N. Cerveira, C. Correia, S. Doria, S. Bizarro, P. Rocha, P. Gomes, L. Torres, L. Norton, B.S. Borges, S. Castedo, and M.R. Teixeira Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia Leukemia 17 2003 2244 2247 The authors screened a consecutive series of 20 cases of AML diagnosed before 20 years old and identified one with a t(5;11)(q35;p15.5) translocation. Review of reported cases with this translocation suggests that it may be associated with an aggressive clinical course.
46. R. La Starza, P. Gorello, R. Rosati, A. Riezzo, A. Veronese, E. Ferrazzi, M.F. Martelli, M. Negrini, and C. Mecucci Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts Genes Chromosomes Cancer 41 2004 395 399
47. P.A. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard, R. Wooster, N. Rahman, and M.R. Stratton A census of human cancer genes Nat Rev Cancer 4 2004 177 183